Table 5

Multiple Cox regression: best prognostic model for survival probabilities

Model BNo./diedEstimation of coefficient βStandard deviation of estimated βWald's χ statisticP valueHazard ratio
Deletion status 335/130 — — 9.784 (2 df) .007 — 
    No 276/110 Baseline — — — — 
    One side of breakpoint 38/7 −0.870 0.391 4.944 .026 0.419 
    Whole breakpoint 21/13 0.623 0.302 4.251 .039 1.864 
Age, fully completed years 335/130 0.018 0.007 5.627 (1 df) .018 1.018 
Spleen enlargement, cm 335/130 0.058 0.016 13.519 (1 df) < .001 1.059 
Model BNo./diedEstimation of coefficient βStandard deviation of estimated βWald's χ statisticP valueHazard ratio
Deletion status 335/130 — — 9.784 (2 df) .007 — 
    No 276/110 Baseline — — — — 
    One side of breakpoint 38/7 −0.870 0.391 4.944 .026 0.419 
    Whole breakpoint 21/13 0.623 0.302 4.251 .039 1.864 
Age, fully completed years 335/130 0.018 0.007 5.627 (1 df) .018 1.018 
Spleen enlargement, cm 335/130 0.058 0.016 13.519 (1 df) < .001 1.059 

Survival times of patients with imatinib or stem cell transplantation in the first chronic phase were censored.

df indicates degrees of freedom; —, not applicable.

For the candidate variables deletion status, age, spleen enlargement, blasts, basophils, eosinophils, platelet count, haemoglobin, white blood cell count, and sex, 335 patients with complete cases were available of whom 130 patients died.

Close Modal

or Create an Account

Close Modal
Close Modal